FaegreBD Represents Spectranetics in Acquisition of AngioScore Inc.

Faegre Baker Daniels represented The Spectranetics Corporation, a Colorado Springs-based medical device company, in acquiring AngioScore Inc. in a $230 million cash purchase, along with contingent commercial and regulatory milestone payments. The transaction closed June 30, and was funded with the proceeds from a $230 million public offering of convertible notes.

FaegreBD's corporate attorneys Doug Wright and Matt Stamski were principal attorneys serving Spectranetics' transaction team, with assistance from attorneys from eight different FaegreBD offices. Wright and corporate partner John Marcil led the offering team in securing funding from the public offering.